Trinity College

Trinity College Digital Repository
Senior Theses and Projects

Student Scholarship

Spring 2015

The Effect of Serrate Transmembrane Domain Substitution on
Notch Signaling
James Z. Curlin
Trinity College, james.curlin@trincoll.edu

Follow this and additional works at: https://digitalrepository.trincoll.edu/theses
Part of the Molecular Genetics Commons

Recommended Citation
Curlin, James Z., "The Effect of Serrate Transmembrane Domain Substitution on Notch Signaling". Senior
Theses, Trinity College, Hartford, CT 2015.
Trinity College Digital Repository, https://digitalrepository.trincoll.edu/theses/482

TRINITY COLLEGE

THE EFFECT OF SERRATE TRANSMEMBRANE DOMAIN SUBSTITUTION ON NOTCH SIGNALING
BY

JAMES CURLIN

A THESIS SUBMITTED TO
THE FACULTY OF THE DEPARTMENT OF BIOLOGY
IN CANDIDACY FOR THE BACCALAUREATE DEGREE
WITH HONORS IN BIOLOGY

DEPARTMENT OF BIOLOGY

HARTFORD, CONNECTICUT
1 May 2015

THE EFFECT OF SERRATE TRANSMEMBRANE DOMAIN SUBSTITUTION ON NOTCH SIGNALING

BY

JAMES CURLIN

Honors Thesis Committee
Approved:
______________________________________________
Robert J. Fleming, Advisor
______________________________________________
Kent D. Dunlap
______________________________________________
Terri A. Williams
Date: ________________________________________

ii

Table of Contents
Section

Page Number

Abstract………………………………………………………………………………………..1
Introduction…………………………………………………………………………………....2
Materials and Methods……………………………………………………………………….15
Results………………………………………………………………………………………..19
Discussion……………………………………………………………………………………25
References……………………………………………………………………………………29

Acknowledgments
I would like to sincerely thank the Trinity College Biology Department for providing
me the opportunity to engage in unique research over the past several years. Dr. Terri
Williams and Dr. Kent Dunlap were crucial to the completion of this thesis, by providing
much needed feedback and advice.
Most importantly, I would like to thank Dr. Robert Fleming. Over the past four years
he has been my research advisor, and mentor throughout my college experience. He
introduced me to the world of academic research, and has helped me to further my
aspirations of being a scientist.

iii

Abstract
The Notch signaling pathway is a crucial means by which organisms differentiate
cells during development. Notch is regulated primarily through the interaction of a Notch
receptor protein and a ligand protein, in two specific ways. Cis-inhibition occurs when both a
ligand and receptor are present on the same cellular membrane. This results in the cis-ligand
binding to the receptor and preventing the ligand on an adjacent cell from binding and
activating the receptor. Alternatively, trans-activation occurs when the ligand and receptor
are on adjacent cells, and results in the activation of the Notch pathway. Both the receptor
and ligand proteins are transmembrane proteins that are cleaved first extracellularly by a
metalloprotease, and then intracellularly by a γ-secretase. While the cleavages in the receptor
protein have been found to be crucial for proper Notch activation, the role of the ligand
cleavages is much less well defined. Previous studies have found that the cleavage rate of the
ligand may be inversely correlated to Notch activation. We postulated that the extracellular
cleavage of Serrate, a ligand for Notch, by a metalloprotease serves as a means of inhibiting
Notch activation, possibly by affecting the endocytosis of the ligand molecule. To test this
hypothesis, we replaced the transmembrane domain of a truncated form of Serrate with that
region from non-cleavable human tyrosine kinase receptor DDR2 (discoidin domain-receptor
2), and show that preventing this cleavage is insufficient to restore Notch activation. These
findings suggest that an additional extracellular 65 amino acid segment near the
transmembrane domain may be necessary to restore wild-type levels of Notch activation.
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Introduction
Intercellular communication is crucial for growth and development of specific cell
types in multicellular organisms. One primary means of cell communication is through cell
signaling pathways. Individual cells signal to surrounding cells, providing them with
instructions for differentiation, growth and even apoptosis (Artavanis-Tsakonas et al., 1999).
Notch signaling is one such communication pathway and is responsible for important
developmental changes in organisms ranging from Drosophila melanogaster to Homo
sapiens. When Notch signaling is disrupted, severe developmental defects can occur. Early
studies in Drosophila showed that various Notch mutations caused hypertrophic growth of
neural tissue, accompanied by significant hypotrophy of epidermal tissue (Jimenez and
Campos-Ortega, 1982; Xu et al., 1990). This results from the Notch pathway controlling the
differentiation of cells by lateral inhibition. Neural cells normally develop in clusters: a
central cell is determined to become a neuroblast, and signals to the surrounding cells to shut
off their proneural genes, resulting in their adopting an epidermal fate (Technau et al., 1987).
Without the Notch pathway to signal to the surrounding cells, none of the proneural genes are
shut down, producing a phenotype with no epidermis and hypertrophic neural tissue (Heitzler
and Simpson, 1991). Other studies in mammalian systems showed that Notch also controls
cell differentiation in systems outside of neurogenesis, such as controlling cell fate in the
endocrine and exocrine pancreas (Apelqvist et al., 1999). Furthermore, Notch can direct cell
fate not only through promoting differentiation, but by inhibiting cell differentiation as well,
a mechanism by which Notch controls muscle cell fate (Shawber et al., 1996).
Problems resulting from mutations arising in the Notch pathway have been implicated
in a number of human diseases. Such mutations can affect the development of the liver, heart,
2

skeleton, and kidneys. One example is Alagille syndrome, which is caused by mutations in
either the Jagged1 ligand or the Notch2 receptor (Oda et al., 1997). Another example is
Hajdu-Cheney syndrome, which is linked to a mutation in the Notch2 receptor and is
responsible for osteoporosis, renal cysts, and problems with craniofacial bone structure in the
craniofacial region (Iwaya et al., 1979). Mutations in other Notch receptors have been
implicated in cardiac disease, and cerebral autosomal dominant arteriopathy with subcortical
infarcts and leukoencephalopathy (CADASIL; Penton et al., 2012).
The Notch pathway is extremely conserved, and therefore research on Drosophila has
clinical relevance for humans, despite minor differences between the mammalian and
Drosophila Notch systems. These differences include the mammalian receptor undergoing
additional processing prior to its presentation on the cell membrane (Kopan and Ilagan, 2009;
Westhoff et al., 2009). Many features that control the Notch pathway remain unknown.
While the receptor molecule must undergo a series of proteolytic processing steps that allows
the signal to reach the nucleus, the ligands, which interact with and regulate the receptor, are
also similarly processed for a currently unknown reason. Therefore, the purpose of my
experiments in this work is to provide insight into what role ligand processing, specifically
metalloprotease cleavage has on Notch activation. This is achieved by generating a novel
form of the ligand Serrate.
Structure of Notch Receptor
Drosophila melanogaster has long been a favored research animal by geneticists for a
variety of reasons. It has a relatively short life cycle and produces many offspring in a short
period of time. Compared to many species, it also has relatively simple genetics with its
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genome consisting of merely four pairs of chromosomes. The Notch pathway has been
extensively studied in Drosophila, and it is the focus of this thesis.
The Notch gene product functions as a signal receptor and belongs to a group of
single-pass transmembrane proteins (Wharton et al., 1985). This receptor interacts with the
Delta/Serrate/Lag-2 (DSL) family of ligands to constitute the major interacting elements of a
cell-signaling pathway (Fehon et al., 1990). Drosophila Notch is a single protein and was
first characterized by analyzing the mRNA sequence obtained through the overlapping of
cDNA clones (Wharton et al., 1985). After determining the DNA base pair sequence of
Notch, the correct reading frame was determined and a predicted protein, of ~300 kDa in size,
was isolated. The protein indicated the presence of an extracellular domain, a transmembrane
domain and an intracellular domain.
The Notch receptor’s extracellular domain (NECD) includes 36 epidermal growth
factor (EGF)-like repeated sequences (ELRs), which play a key role in proper Notch
signaling, as well as three lin12-Notch (LNR) repeats that are also cysteine-rich (Fig. 1).
ELRs 11 and 12 play a key role in Notch’s ability to interact with both the Delta and Serrate
ligands and are sufficient to induce cells expressing Notch or Delta to aggregate (Rebay et al.,
1991). This structure-function specificity appears highly conserved, as repeats 11 and 12
serve the same role in the Xenopus Notch homolog. However, the remaining ELRs appear to
have contrasting effects in Notch-Delta and Notch-Serrate interactions in Drosophila.
Normally, the binding of the receptor and ligand surface proteins causes cells in culture to
stick together in aggregations. Removal of extraneous ELRs causes an increase in
aggregation of Notch-Delta cells, but it produces no such increase in the aggregation of
Notch-Serrate cells (Rebay et al., 1991).
4

The ELRs play a key role in maintaining the structural integrity of the Notch
molecule. Each ELR has six highly conserved cysteines that generate disulfide bonds and
provide a highly consistent structure, even with some variation in the composition and
number of other non-cysteine amino acids in the repeat (Fig. 2). ELRs 24 through 29 have
been implicated in ligand interactions that inhibit Notch signaling (Kelley et al., 1987).
ELRs also bind calcium ions, which
influence the receptor’s affinity for the
ligand during activation and inhibition
(Cordle et al. 2008).
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Figure 1: The Notch receptor protein structure. The
extracellular domain consists of 36 ELRs and 3 LNR repeats.
The intracellular domain consists of the RAM region, 7
cdc10/ANK repeats, Nuclear localization sequences (NLS), a
polyglutamine chain called the OPA, as well as a PEST
region that controls degradation
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Figure 2: Structure of an EGF-like repeat. It
has 6 highly conserved cysteines (red) that
maintain the structure with disulfide bonds
(Yamamoto et al., 2012).

The Notch intracellular domain (NICD) contains several structural motifs, including
a large segment of repeating glutamines, known as OPA, for which no purpose has been
determined, 6 cdc10/ankyrin repeats (ANK), nuclear localization sequences (NLS) that
ensure the NICD goes to the nucleus, a RBPjk association module (RAM), which has a high
5

affinity for binding to various transcription factors in the nucleus and finally a PEST domain
that controls the degradation of the NICD (Struhl and Adachi, 1998; Deregowski et al., 2006,
Kopan and Ilagan, 2009). In addition to the intracellular and extracellular domains, the Notch
receptor has a transmembrane domain (TMD), which is responsible for bridging the cellular
membrane and anchoring the protein in place. Once the receptor has bound to a ligand to
activate the signaling pathway, it undergoes several cleavages that first remove the
extracellular domain and then the intracellular domain from the molecule.
Notch Ligands
The receptor alone is not capable of activating the signaling pathway and is regulated
through its interaction with the ligands, resulting in either activation or inhibition. Several
ligands of Notch exist in mammals, Drosophila and C. elegans. The best studied ligands
belong to the DSL (Delta/Serrate/LAG-2) family, (although other ligands may exist; Kopan
and Ilagan, 2009). Each ligand in this family is identified by three structural motifs, a DSL
region found at the N-terminal end of the extracellular domain, a DOS domain (Delta and
OSM-11-like proteins), and a series of ELRs, similar those found in the Notch receptor itself
(Fig. 3). While the ligand Serrate and its mammalian homolog Jagged consist of 14 and 16
ELRs respectively, and have a cysteine-rich domain, the ligand Delta (in mammals) has only
eight or nine ELRs and lacks the cysteine-rich domain (Kopan and Ilagan 2009). ELRs 4-6 of
Serrate are known as the Notch-inhibitory region (NIR) and when any single repeat is
removed the ligand loses all inhibitory function (Fig. 3A; Fleming et al., 2013). These
ligands are also transmembrane proteins and therefore have a transmembrane domain and
intracellular domain as well.
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Figure 3: A) Structure of the Serrate ligand, characterized by a DSL domain,
14 ELRs and a cysteine-rich domain. B) The structure of the Delta ligand
consisting of the 9 ELRs and lacking a cysteine-rich domain.

Mechanism of trans-activation/cis-inhibition
The membrane bound Notch receptor interacts with its ligands in two specific ways,
trans-activation and cis-inhibition. The first ligand-receptor interaction occurs when both
proteins are present on the same cell membrane. In this case, the ligand interacts with the
receptor in a currently unknown manner and prevents the receptors from undergoing transactivation with any adjacent cells (Fig. 4A). This process is known as cis-inhibition
(Jacobsen et al., 1998). When the Notch receptor and a ligand are present on separate, but
adjacent cells, the ligand binds to at least ELRs 11-12 in Notch. This creates a
conformational change, revealing an extracellular metalloprotease cleavage site, and
subsequently initiating the extracellular cleavage of the Notch protein called S2 (Fig. 4B;
Mumm et al., 2000).
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Figure 4: Regulation of Notch pathway through ligand-receptor interactions. A) Cis-inhibition: The receptor and ligand are
present on the same cell surface, so the receptor is prevented from interacting with the adjacent ligand. B) Trans-activation:
The Notch receptor binds to the ligand, which triggers a conformational shift, allowing the receptor to be cleaved and
activating the signal

Proteolytic Cleavage of the Receptor Protein
The kuzbanian (kuz) gene codes for an ADAM (a disintegrin and metalloprotease)
protein that is responsible for the extracellular cleavage in Notch receptor processing prior to
signal transduction. This protein has a conserved zinc-binding region as well as several
cysteines that allow the binding of integrin receptors. The kuz protein shares a close
homology with a mammalian homolog, BMP (bovine metalloprotease) and other ADAM
proteins cause proteolytic cleavages to Notch as well, such as TACE (TNF-alpha converting
enzyme), which uses a proteolytic cleavage to release TNF-α from its transmembrane domain
(Brou et al., 2000). In Notch, this cleavage allows for the shedding of the extracellular
8

domain, which subsequently leads to another cleavage of Notch by a γ-secretase (Mumm et
al., 2000).
After the extracellular cleavage of Notch by ADAM, the NECD is endocytosed by the
ligand-expressing cell (Shimizu et al., 2002). This allows room for a presinilin/γ-secretase,
which may normally be blocked by the presence of the extracellular domain, to interact with
and cleave the intracellular domain of Notch at the S3 site (Fig. 4B). This initiates
transcription regulation by releasing the intracellular domain into the cell.
Following the intracellular S3 cleavage by γ-secretase, the Notch intracellular domain
(NICD) moves to the nucleus and regulates transcription through a series of nuclear
intermediates. One such nuclear factor is the Suppressor of Hairless (Su(H)), which requires
the ankyrin (ANK) repeats of the NICD to be sequestered in the cytoplasm (Fortini and
Artavanis, 1994). Once the Notch receptor is bound in trans to the ligand, Su(H) is
translocated into the nucleus. The ANK repeats then interact with the Su(H) protein to recruit
Mastermind, a coactivator necessary for recruiting a transcription activation complex (Kopan
and Ilagan 2009).
Ligand Processing
Protein cleavages are not only necessary for the receptor to function properly, but are
crucial for the ligand as well. The ligands Serrate and Delta are cleaved extracellularly by
metalloproteases produced by kuzbanian or TACE (Lavoe and Selkoe, 2003;Qi et al., 1999).
However, when secreted forms of these ligands were expressed, that are comparable to forms
that result from ADAM cleavages, they generated a phenotype similar to loss of function
Notch mutation (Sun and Artavanis-Tsakonas, 1997). It is postulated that the ligands must
9

undergo a special endocytosis to activate Notch (Parks et al., 2000). After binding to the
receptor protein, the ligand is then tagged with ubiquitin (Deblandre et al., 2001). This allows
epsin to trigger the endocytosis of the ligand, which tugs on the NECD to reveal a
metalloprotease cleavage site (Wang and Struhl, 2004). Given the Parks model of Notch
activation (2000), cleaving the extracellular domain of the ligand might reduce its ability to
cause a conformation change in the receptor, hence antagonizing Notch activation and
emphasizes the sequence of events necessary for activation.
Effect of Altering the Ligand Protein Structure
Altering the structure of Serrate can have a significant impact on the ligand’s ability
to activate Notch. The Serrate construct Minigene is a truncated form of the ligand that only
contains the signal peptide, DSL domain, and the first six ELRs in the extracellular domain
(Fig. 5B). This construct was unable to activate Notch when ectopically expressed (Fig. 6E;
Fleming, personal communication). However, adding a 65 amino acid sequence to the
extracellular domain of Serrate restored its trans-activation capabilities (Fig. 6K).
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A

B

C

D

Figure 5: Variations of the Serrate molecule. A) Wild-type Serrate. B) Minigene Serrate construct with a truncated
extracellular domain containing the first 6 ELRs, and a small amino acid chain directly adjacent to the
transmembrane domain. C) DDR2 Serrate construct containing the minigene construct with a DDR2
transmembrane domain substituted in. D) DDR265 Serrate construct containing the DDR2 construct with an
additional 65 amino acids added immediately adjacent to the transmembrane domain.
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Figure 6: Previous Serrate constructs and their ability to activate and inhibit Notch. A, D, G, and J) show ectopically
expressed ptc-Serrate using GFP in several different constructs. B, E, H, and K) Cut expression of Notch activation
in various Serrate constructs. C, F, I, L) merged images of the other images. B) Trans-activation and cis-inhibition of
Notch in ectopically expressed wild-type Serrate. The white line indicates cut expression when no ectopic Serrate is
present. E) Minigene construct, a truncated Serrate that only has the first 6 ELRs, only produces cis-inhibition, and
no trans-activation of Notch. H) Ncleave7, a construct that changed one amino acid in the metalloprotease cleavage
site, produces excess Notch activation. K) MG65, a construct that includes minigene and 65 additional amino acids,
produces wild-type trans-activation and cis-inhibition.
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Figure 7: Western Blot showing the cleavage rate of minigene (MG) and MG65. The extracellular domain of the
minigene is significantly more abundant than that of the MG65, indicating that MG is cleaved at a much higher rate
than MG65 (Fleming, personal communication). The MG65m lane shows the cleavage rate of a mutated MG65
construct.

Furthermore, the minigene construct has also been shown to cleave at a significantly
higher rate than MG65 (Fig. 7) which indicates that a correlation between the rate of
cleavage and Notch activation capacity may exist. The first attempt to test this correlation
resulted in the creation of the Ncleave7 construct, which substituted two amino acids in the
metalloprotease cleavage site, in an effort to block the cleavage from occurring. While
Ncleave7 did produce an over activation of Notch, (Fig. 6H) it was later determined that the
cleavage was not completely prevented (Fleming, personal communication).
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Goals of the project
As stated previously, while the cleavages of the Notch receptor serve the clear
purpose of facilitating the release of the NICD, the purpose of cleaving the ligands is still
unknown. Based on the initial evidence provided by previous constructs (Fig. 6, 7), we
theorized that the cleavage of the ligand Serrate functions as a down regulator of the Notch
signal. To study this phenomenon, I sought to interrupt the metalloprotease cleavage of
Serrate. Discoidin domain receptors (DDR) are a group of transmembrane tyrosine kinase
proteins that control the interactions between cells and collagen. While DDR1 has been
shown to be cleaved by metalloproteases such as membrane-type matrix metalloproteinase
(MT-MMP) and release an extracellular domain in a manner similar to Serrate and Notch,
the transmembrane domain of DDR2 undergoes no such cleavage by a metalloprotease (Fu et
al., 2013). The cDNA encoding the transmembrane and juxtamembrane regions of the DDR2
was used to replace the comparable region of Serrate to eliminate metalloproteinase cleavage.
The first goal of this project was the generation of a Serrate minigene molecule, with the
transmembrane domain substituted for the theoretically uncleavable DDR2 (discoidin
domain receptor) transmembrane domain from humans. Theoretically, if the cleavage of the
ligand is stopped, then the ligand will always trigger the conformational change, and Notch
will activate at a much higher rate.
In order to observe the effect of ectopically expressed DDR2 Serrate on Notch, and
consequently its effect on wing development in D. melanogaster, the construct is linked to
the patched (ptc) promoter and the Gal4/UAS expression system with green fluorescence
protein (GFP) acting as the reporter gene (Brand and Perrimon 1993). This allows the
expression of Serrate to occur ectopically in a known pattern and can be measured using the
13

GFP. The second goal was to create a construct similar to DDR2, but with the Serrate MG65
molecule, rather than the minigene as the basis for the construct. If the new construct results
in an overexpression of Notch, then it is very clear that some portion of the 65 additional
amino acids interacts in a presently unknown manner with the Notch receptor, and would
further the hypothesis that the cleavage acts to down regulate Notch.
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Materials and Methods
Creation of Serrate Construct DDR2
The initial DNA used was the full-length Serrate Bsp tom DNA in pUAST attB
vector (Biscof, et al. 2007), and is called Xho+. Xho+ was initially cut with the restriction
digest enzymes XhoI and XbaI (NEB) simultaneously. The DNA from pUAST attB Xho+ #4
(Fleming, personal communication) was used as a control. For all digests, a lambda/Hind III
ladder (NEB) was used for fragment size estimations. Inoculations were made of the DDR2
construct, which was initially synthesized and cloned by InVitrogen. These inoculations were
purified according to the same procedure mentioned previously. Each inoculation was
analyzed using Nanodrop to determine the concentration of the DNA.
Using gel electrophoresis, the Xho+ digest was separated out on using the Extraction
Kit procedure (www.qiagen.com). A ligation of the two DNA fragments was performed
using Thermo Quick Ligase according to the Rapid DNA Ligation Kit procedure (Thermo
Scientific). The ligated DNA (XhoDDR2) was transformed into NEB 5-alpha competent E.
coli (NEB) according to the manufacturer’s protocol and plated in varying quantities onto
LB/AMP agar plates. PCR was used to determine if the insert was correct with the primer
Xho3 end (5’GCGTCTGGCTTATCGCTCGAGTTCGGGAATGAACTTAAC3’) and primer
5119-5080 (5’CACACTGTGTAGGATGTTCTTAGCGAAGAGAAGAGT3’), with Bsp tom used
as a control. In order to test the orientation of the insert, both samples were digested
sequentially with first XbaI and then EcoR1.
Both XhoDDR2 and an additional sample of Xho+ #4 were digested sequentially with
XbaI and EcoR1, and the lowest band from both digests were isolated and purified according
to the QIAquick Gel Extraction Kit procedure (www.qiagen.com) over a single column.
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These fragments were ligated with a pUAST attB vector that had been cut with EcoR1, using
the ligation procedure (Thermo Scientific). NEB 5-alpha competent E. coli (NEB) was used
for the transformation, and the cells were plated on LB/AMP agar plates in varying quantities.
Each sample was prepped for sequencing first by increasing the concentration of each
sample by using vacuum dehydration (Savant SpeedVac Plus SC110A). One microgram of
DNA was resuspended, and the primer 4336
(5’GCCGGTGGCCGCTCTTAGGAACTGGTGCTGCC3’) was added to the solution. These
samples were sequenced by Genewiz through the University of Connecticut Molecular Core
Facility. The final DNA construct was sent to Genetic Services, Inc. where it was injected
into Drosophila embryos to generate transgenic lines.
Drosophila crosses used for phenotypic observations
To determine the phenotypic effects of the constructs, several crosses involving the
injected flies were necessary. Virgin females were collected from the promoter constructs
H2S2/H2S2 or ptc;Gal4 UAS GFP lines. These females were crossed separately with males of
the DDR2/attp2 homozygous lines. The H2S2/H2S2 cross was placed in 25°C incubation,
while the ptc;Gal4 UAS GFP cross was placed in 18°C to slow development to avoid
embryonic lethality associated with high levels of expression. After 3 days, the adults were
moved to fresh tubes of food in to grow the fly lines. This process was repeated several times
until sufficient animals were obtained.
Wing Dissection
As the adult Drosophila from the H2S2/H2S2 cross emerged from their pupal cases, the
wings were removed from adult flies and stored in xylene. Approximately ten wings were
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placed on a microscope slide, and excess xylene was removed. Permount (Fisher Scientific)
was used to mount the wings, and a coverslip was placed on the slide. This was allowed to
dry for several hours.
Immunofluorescence Staining
Larvae from the ptc;Gal4 UAS GFP cross were dissected in phosphate buffered saline
(PBS), and the imaginal wing discs, while still attached to the larval heads, were placed in
4% paraformaldehyde in PBS for approximately 20 minutes. The heads were washed with
PBS four times. At this point, the PBS was replaced with blocking solution (1X PBS, 0.002%
Saponin and 0.003% Normal Goat Serum), and the wing discs were kept at a cool
temperature for 2 hours. The blocking solution was replaced, and 15µL of primary antibody
mouse anti-cut 2B10 (Developmental Studies Hybridoma Bank) was added, and incubated
overnight. The following day, primary antibody solution was removed and the wing discs
were washed with 4 changes of PBS, and placed in fresh blocking solution. After several
hours, the blocking solution was replaced with 1 µL of the secondary antibody Alexa Fluor
546 goat anti-mouse IgG and allowed to incubate overnight. The following day, heads were
again washed with PBS 4x, and placed in fresh blocking solution. The wing discs were
mounted on microscope slides, and were isolated from the larval heads. Excess solution was
removed, and the discs were covered in glycerol. The wing discs were coverslipped and
observed using a Nikon E600 epi- fluorescent microscope and Spot Diagnostics Software.
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Figure 8: A simplified diagram showing the restriction digests and ligations necessary to generate the
SerDDR2 construct. A) Xho+ Bsp tom was digested with XbaI/XhoI and the smaller fragments were
removed. B) DDR2 synthesized DNA digested with XbaI/XhoI and the smaller fragment was kept. C) The
result of ligating A and B, this was digested with EcoR1/XbaI. D) Same DNA from A, digested with 18
EcoR1/XbaI and the Xba fragment removed E) Bsp tom digested with EcoR1. F) The result of ligating C,
D, and E together.

Results
Construction of SerDDR2
The putatively uncleavable construct SerDDR2 was successfully created by replacing
the transmembrane domain of the minigene Serrate with the transmembrane domain of the
human DDR2 protein. Figure 8 shows the fragments produced by the XhoI/XbaI digest of the
DDR2 inserted piece and the Xho+ vector. The smaller of two fragments of DDR2 (Fig. 9,
lane 1) was isolated from the gel and purified, as was the larger fragment from Bsp tom Xho+
(Fig. 9, lane 4).

1

2

3

4

5

Figure 9: The gel electrophoresis of the XhoI/XbaI restriction digest. Lane 1. DDR2 cut with XhoI/XbaI.
The lower band was extracted and purified for further use (circled). Lane 2. Uncut DDR2 used as a
control. Lane 3. HindIII lambda ladder used for fragment size determination. Lane 4. Xho+ cut with
XhoI/XbaI. The upper band was extracted and purified for further use (circled). Lane 5. Uncut Xho+
used as a control.
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Following the successful ligation of the two fragments from the XhoI/XbaI digest (Fig.
8C), the XhoDDR2 construct was subsequently digested by EcoR1/XbaI, as was Bsp tom
Xho+. Figure 10 shows the resulting fragments produced by the digest, excluding Xho+. The
lower band (Fig. 10, Lane 1) was extracted and purified. This fragment was then ligated with
the fragment obtained from Xho+, as well as Bsp tom attB that had been digested with EcoR1
alone (Fig 8C-F).

1

2

3

4

Figure 10: An EcoR1/XbaI restriction digest used as a test for two different samples of XhoDDR2. Lane 1.
The first sample of XhoDDR2 with the desired fragment present (circled). Lane 2. The second sample of
XhoDDR2 lacking the desired fragment. Lane 3. MG65 DNA also digested with EcoR1/XbaI to serve as a
control. Lane 4. HindIII lambda ladder for fragment size comparison.

Several colonies resulted from the previously mentioned ligation, so a 50-colony PCR
was performed (Figure 11). Many samples showed the presence of the correct insertion band,
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and several were used for further testing (Lanes 1, 2, 3, 6, 9, 10, 14 and 15). Ultimately,
samples from lanes 3 and 6 were sent for DNA sequencing and verification, and both
appeared to have the correct sequence.

1 2 3 4 5 6 7

14 15 16 17 18 19 20 21 22

30 31 32 33 34 35 36 37 38 39 40

8 9 10 11 12 13

23 24 25 26 27 28 29 30

41 42 43 44 45 46 47 48 49 50

Figure 11: 50-colony PCR of the SerDDR2 construct following the final ligation. HA3
primer and 5119-5080 primer were used, and HAMG DNA was used as a control. Lanes
with the desired band (such as the one circled) indicate the correct ligation. Each of these
was later tested for the orientation of the insert. Lanes 3, 6, and 15 were tested and all had
the insert in the correct orientation. The samples from lanes 3 and 6 were sent for
sequencing.
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Figure 12: Imaginal wing discs of the H2S2/ H2S2 and ptc; Gal4 UAS GFP cross. Dorsal is up and posterior
is to the right in each panel. A) A wild-type wing disc showing ectopic Serrate expression under the
patched (ptc) promoter using green fluorescence protein (GFP) (Fleming, personal communication). B)
CUT expression of Notch activation affected by ectopic Serrate in a wild-type disc. Cut is expressed
adjacent to Serrate expression in ventral disc areas (red stripes). Notch is not activated where Serrate is
expressed at high levels, as seen by the gap in CUT expression. C) Merged image of A and B. D) ptc-GFP
expression of Serrate in the DDR2 construct. E) CUT expression of Notch activation in the DDR2
construct. Gap in CUT expression across the margin is present. F) Merged image of D and E

Upon completion of the SerDDR2 construct, genetic crosses were performed to
express the transgene in a pattern driven by the promoter of the gene patched (ptc). The
imaginal wing discs were collected. The wing discs taken from the H2S2/ H2S2 and ptc;Gal4
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UAS cross were processed for Cut expression as a marker for Notch activity and observed
(Fig. 12).
When DDR2attp2 is expressed via ptc, strong cis-inhibition is observed (Fig. 12E).
Occasionally, a very small amount of activation of Notch occurs on the posterior side of the
patched Serrate expression pattern, in some discs (Fig. 12E,F). However, this activation is
extremely limited compared to wild-type activation of Notch (Fig. 12B, C), and many discs
showed no activation at all.
The H2S2/ H2S2 and DDR/2attp2; A5/TM6 B cross produced several different
phenotypes (Fig. 13). All flies developed wings, but the vast majority of flies produced
dominant-negative wings, a scenario in which the altered copy of Serrate inhibits the wildtype copy. These wings display severely stunted growth and heavy wing veination (Fig. 13G,
H). A smaller percentage of animals showed wings with severely nicked edges, similar to the
phenotype produced by Serrate mutants (Fig. 12E and F).
Construction of SerDDR265 is currently in progress, following the same procedures
used for the construction of SerDDR2. However, this construct uses MG65 as its framework
rather than the minigene, and therefore contains the additional 65 amino acids that were
shown to restore Notch activation (Fig. 6K). This should allow us to determine if the
cleavage of Serrate has an effect on Notch activation independent of the effect of the
additional amino acids.
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Figure 13: Wings collected from the H2S2/ H2S2; DDR/2attp2 cross with ptc expressed Serrate. A) Wildtype adult wing that is phenotypically normal. B) Wild-type wing with a wild type Serrate construct
expressed by H2S2. C) Wing expressing activated Serrate construct via H2S2. D) Wing expressing a
dominant-negative Serrate construct via H2S2 E), F) Adult wings expressing DDR2/attp2 via H2S2
displaying severe wing nicking, but still somewhat developed. G), H) Adult wings expressing DDR2/attp2
via H2S2 displaying the dominant-negative phenotype with severely reduced wing size and inhibited
development. All images are at same magnification.
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Discussion
The results produced by the SerDDR2 construct, as shown in the adult wings and
imaginal wing discs (Fig. 11,12), do not support the hypothesis that the cleavage of Serrate
functions as a down regulator of Notch activation. Previous studies have shown that forms of
Serrate such as the minigene construct, which are cleaved at a significantly higher rate than
wild-type Serrate, also lack activation capacity. However, Serrate constructs such as MG65,
which are cleaved at levels significantly lower than the minigene (Fig. 7), are capable of
activating Notch at levels equivalent to wild-type as well (Fleming, personal communication).
Therefore, it appears that the cleavage rate of Serrate may be inversely correlated to the rate
of Notch activation.
I predicted that preventing the cleavage of Serrate would increase activation of Notch
drastically. Hence a phenotype in wing discs comparable to that seen in Figure 6H was
expected of the SerDDR2 construct. On the contrary, the SerDDR2 construct resulted in
primarily Notch inhibition with perhaps an extremely small amount of Notch activation in
some discs. This could be explained by several different possibilities as outlined below.
The MG65 Serrate construct differs from the minigene construct by the presence of
an additional endogenous 65 amino acids chain located adjacent to the transmembrane
domain. This additional chain of amino acids has very little homology with the same region
in the mammalian homologous ligand Jagged (Lindsell et al., 1995), and no additional
functions have been attributed to this region so far (Fleming, personal communication).
However, the additional 65 amino acids allow MG65 to activate Notch at a significantly
higher rate than the minigene construct. This suggests that a previously undescribed
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component in these 65 amino acids contributes to proper activation of Notch. Part of the
reason for constructing DDR265 is to further examine whether that additional chain can
permit Notch activation, in the absence of a metalloprotease cleavage in the DDR2 construct.
It is possible that the cleavage does, in fact, down regulate Notch activation, but that
activation itself requires an additional component not present in DDR2. Without this
unknown component, Notch may not activate at significant levels regardless of ligand
cleavage. This could explain the largely dominant-negative effects observed in the adult
wings (Fig. 13G, H) when DDR2attP2 is expressed with an occasional hint of activity in
some wings (Fig. 13E, F).
Most adult wings observed from the SerDDR2 construct produced the dominantnegative phenotype (Fig. 12G, H). This is consistent with adult wing phenotype observed
previously in the minigene construct (Fleming, personal communication), indicating that
Notch activation does not occur, or occurs in very small amounts. However, several
individual flies produced wings that were much more developed, and thus do not display as
strong of a dominant-negative phenotype, though these flies were not nearly as abundant as
the other phenotype. Wings that were not dominant-negative were characterized by severe
wing nicking, a trait often present in flies with reduced Notch activation (Fleming, personal
communication; Thomas et al., 1991). This suggests that in some SerDDR2 flies, Notch
activation was partially restored. Unfortunately, because this phenotype is not present in all
offspring, it seems unlikely that it is solely the result of the SerDDR2 construct. Ultimately,
the cause of the unexpected phenotype is still unknown.
Another factor that could be influencing the results is the substituted SerDDR2
transmembrane domain itself. While it has been shown to not be cleaved in humans, its
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cleavage or non-cleavage has not yet been verified in Drosophila (Fu et al., 2013). Many
components that control metalloprotease cleavage have not yet been fully described, and it is
possible that some of these could initiate a cleavage of the DDR2 transmembrane domain in
flies in a manner that has not been observed in humans. If so, the SerDDR2 construct could
still be getting cleaved, which would then down regulate Notch. It will be necessary to
measure the abundance of cleaved material using a western blot to rule out this scenario as an
explanation. Consistent with this explanation are the properties of metalloproteases
themselves.
Metalloprotease cleavage sites are shown to be more “fluid” than many types of
proteases because they are less sequence specific (Fu et al., 2013). Despite altering an amino
acid within the cleavage site of the Serrate construct Ncleave7 and having this result in
excessive Notch activation when expressed, the protein was still capable of being cleaved
(Fig. 7; Fleming, personal communication). Therefore, it is possible that the SerDDR2
construct is still cleaved, despite the complete absence of the metalloprotease cleavage site
used in humans.
Construction of SerDDR265 is still in progress due to a number of technical problems,
specifically issues relating to ligations. Once it is completed, the results should provide
insight into the role of ligand cleavage on Notch activation. If the additional 65 amino acids
present in the MG65 construct that restore its ability to activate Notch similar to wild type
Serrate are important for its activity, then I predict that the SerDDR265 construct will overactivate Notch (Fig. 14). This is based on the idea that the cleavage functions as a down
regulator, because SerDDR265 would essentially be an uncleavable form of MG65. However,
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if SerDDR265 does not over activate Notch, then it is possible that the cleavage itself might
be required for Notch activation, rather than serving as a down regulator.
For further study, a control construct that contains an additional 65 amino acids that
are not native to Serrate would help confirm if some factor in that region plays a key role in
Notch activation. Otherwise, the ligand may rely on a spacing mechanism to activate the
receptor. If an unknown factor does exist, then it could revolutionize the current
understanding of the ligand’s role in Notch.

DDR

A
Cleavage: Increase
Notch activation: None

B
Cleavage: None
Notch activation: None

D
Cleavage: Normal
Notch activation: Normal

C
Cleavage: None
Notch activation: Increase?

Figure 14: Variations of the Serrate molecule, cleavage rate and their effect on Notch. A) Ser minigene, a
truncated form that displayed an increased cleavage rate and no Notch activation. B) DDR2 Serrate
construct containing the minigene construct with a DDR2 transmembrane domain substituted in. It was not
cleaved and produced no Notch activation C) DDR265 Serrate construct containing the DDR2 construct with
an additional 65 amino acids added immediately adjacent to the transmembrane domain. This construct is
not cleaved and should display increased Notch activation. D) Ser MG65, the minigene construct with an
additional 65 amino acids attached. Displayed cleavage rates and Notch activation.
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